Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
Medtronic plc
Last earnings +5.7% on 2026-06-03
Healthy net margin (13.9%).
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
Medtronic plc shows $33.5B in FY2025 revenue (+3.6% YoY), a 13.9% net margin, and 9.7% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro$19/mo · cancel anytime
Sources: SEC EDGAR (CIK 0001613103, latest 10-Q filed 2026-02-24) · EODHD · rules-based read · as of 6/17/2026, 6:09:25 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $30.1B | $31.7B | $31.2B | $32.4B | $33.5B |
| Gross profit | — | — | — | — | — |
| Operating income | $4.48B | $5.75B | $5.49B | $5.14B | $5.96B |
| Net income | $3.61B | $5.04B | $3.76B | $3.68B | $4.66B |
| Diluted EPS | $2.66 | $3.73 | $2.82 | $2.76 | $3.61 |
| Net margin | 12.0% | 15.9% | 12.0% | 11.4% | 13.9% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
58 tracked peers · median
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Last 90 days: 0 open-market buys · 2 sales
| 2026-06-08 | KIIL HARRY SKIP EVP & President Cardiovascular | Sell | 3.96K @ $80.44 | $319K |
| 2026-06-08 | KIIL HARRY SKIP EVP & President Cardiovascular | Sell | 228.00 @ $80.45 | $18.3K |
| 2026-06-05 | Blomquist Denise L. Chief Accounting Officer | Tax | 237.00 @ $83.32 | $19.7K |
| 2026-06-04 | KIIL HARRY SKIP EVP & President Cardiovascular | Tax | 6.82K @ $83.32 | $568K |
| 2026-06-04 | Martha Geoffrey Chairman and CEO | Tax | 41.9K @ $83.32 | $3.49M |
| 2026-06-04 | Marinaro Michael EVP, Pres MedSurg and Americas | Tax | 7.47K @ $83.32 | $622K |
| 2026-06-04 | Walter Matthew R. SVP, Chief HR Officer | Tax | 2.84K @ $83.32 | $237K |
| 2026-05-26 | Walter Matthew R. SVP, Chief HR Officer | Exercise | 9.15K | |
| 2026-05-26 | Wall Brett A. EVP & Pres Neuroscience | Exercise | 26.9K |